Media formats available:
Recommended
Prof. Mikhail Kosiborod
- AHA 2019A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
Prof. Freek Verheugt, MD
Prof. Scott Solomon
Prof. Lawrence Leiter, MD
Prof. Mikhail Kosiborod
Prof. Freek Verheugt, MD
Prof. Scott Solomon
Prof. Lawrence Leiter, MD